Avid Radiopharmaceuticals, Inc. (“Avid”) today announced the presentation of interim data from its landmark florbetapir “Image-to-Autopsy” Phase III study. These data come from the first cohort of subjects in the trial and are the first ever Phase III results for an agent designed to image Alzheimer’s disease pathology. Today, Alzheimer’s disease can only be definitely [...]
Posts Tagged ‘at’
Positive Interim Results From Phase III Trial Of Amyloid Imaging Agent Florbetapir F18 Presented At American Academy Of Neurology Annual Meeting
Posted by admin on Nisan 16th, 2010
Posted in Genel 
Tags: Academy, agent, American, Amyloid, annual, at, F18, Florbetapir, from, III, imaging, interim, meeting, Neurology, of, phase, positive, Positive Interim Results From Phase III Trial Of Amyloid Imaging Agent Florbetapir F18 Presented At American Academy Of Neurology Annual Meeting, presented, results, trial. 
No Comments »HairDX Genetic Hair Loss Tests Available In Hong Kong And Singapore At Svenson Hair Centres
Posted by admin on Nisan 16th, 2010
The HairDX Genetic test for predicting the risk of male or female hair loss became available in Hong Kong and Singapore today with the announcement of a distribution agreement between Global Beauty International (HK) Limited (GBIL) and HairDX, LLC.
Global Beauty International will introduce the genetic test to all Svenson Hair Centres in Hong Kong and [...]
Global Scientific Community Meets In Europe To Look At New And Improved Ways To Tackle Infectious Diseases
Posted by admin on Nisan 15th, 2010
Europe’s largest conference on infectious diseases opened on Saturday in Vienna with more than 8,000 experts gathering to share latest knowledge and practice to improve the fight against infectious diseases in Europe and around the world.
“Every year the European Congress of Clinical Microbiology and Infectious Diseases (ECCMID) pools together global knowledge [...]
One Year On Experts Look At The H1N1 Response And Lessons For The Future
Posted by admin on Nisan 15th, 2010
One year on since the first cases of pandemic H1N1 influenza were confirmed in April 2009, experts gathered at Europe’s largest conference on infectious diseases – the European Congress on Clinical Microbiology and Infectious Diseases (ECCMID) – look back at the public health response and identify both lessons learnt and future [...]
Psychologists Investigate Impact Of Romantic Relationships At Work
Posted by admin on Nisan 15th, 2010
Sexual and romantic relationships are a common occurrence in the workplace. In addition to the personal impact of such relationships, they also have the potential to affect the smooth running of organisations.
Dr Lisa Matthewman from the University of Westminster presented her findings at the British Psychological Society’s Annual Conference on [...]
Antiabortion-Rights Advocates ‘Keep Hammering Away’ At Rights, Opinion Piece Says
Posted by admin on Nisan 14th, 2010
Republican-led state legislatures in six states “want to deny women insurance coverage for abortions, even those willing to pay for a special rider with their own dollars,” despite the national health reform law’s (PL 111-148) ban on federal funding for abortion services, Business Week columnist Ann Woolner writes. “You would think [...]
ACM Global Central Lab Demonstrates Quality Expertise At Roswell Park Cancer Institute’s Education Day
Posted by admin on Nisan 14th, 2010
ACM Global Central Laboratory, the global central lab that continually defines the customer-service standard with its flexible approach, will be demonstrating its commitment to sharing knowledge and expertise with Lorrie Divers, director of global quality assurance, presenting to clinical research staff at Roswell Park Cancer Institute at their annual education [...]
Rib-X To Present Data On Delafloxacin At European Congress Of Clinical Microbiology And Infectious Diseases
Posted by admin on Nisan 14th, 2010
Rib-X Pharmaceuticals, Inc., a development-stage antibiotics company with a broad product pipeline based on its innovative discovery platform, announced that an oral presentation of data for delafloxacin, its lead antibiotic candidate, will be given at the 20th European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), April 10-14, in Vienna, [...]